1. Home
  2. PLAB vs NRIX Comparison

PLAB vs NRIX Comparison

Compare PLAB & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Photronics Inc.

PLAB

Photronics Inc.

HOLD

Current Price

$30.54

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$17.07

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLAB
NRIX
Founded
1969
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
PLAB
NRIX
Price
$30.54
$17.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
12
Target Price
$44.33
$30.50
AVG Volume (30 Days)
2.1M
2.5M
Earning Date
05-27-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
9.09
N/A
EPS
1.27
N/A
Revenue
$535,276,000.00
$76,987,000.00
Revenue This Year
$6.70
N/A
Revenue Next Year
$4.96
$48.05
P/E Ratio
$25.78
N/A
Revenue Growth
18.77
99.31
52 Week Low
$18.04
$8.20
52 Week High
$56.00
$22.50

Technical Indicators

Market Signals
Indicator
PLAB
NRIX
Relative Strength Index (RSI) 35.36 56.08
Support Level $21.54 $16.81
Resistance Level $38.00 $17.23
Average True Range (ATR) 2.30 1.28
MACD -0.20 0.10
Stochastic Oscillator 24.48 61.03

Price Performance

Historical Comparison
PLAB
NRIX

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company principally engaged in the manufacturing of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of integrated circuits (ICs) and flat-panel displays (FPDs) and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during fabrication, as well as to a lesser extent, other types of electrical and optical components. The Company has manufacturing facilities in Taiwan, China, South Korea, the United States, and Europe, and generates revenue globally, with Taiwan contributing the majority of total revenue.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: